Moderna’s COVID-19 and Zika patent applications to be investigated
08-09-2020
Moderna unsure of COVID-19 vaccine patent exclusivity
12-08-2020
Ascannio / Shutterstock.com
Biopharmaceutical company, Moderna, has announced that it will not enforce patents related to its COVID-19 vaccine while the pandemic is ongoing, and that it is prepared to license the patents to others after the pandemic is over.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Moderna, COVID-19, vaccine, biopharmaceutical, IP, patents, BARDA, DARPA, Knowledge Ecology International, World Health Organization, USPTO
